June 16-19, 2025

Boston Convention & Exhibition Center

2024 Sessions

Review the sessions from BIO 2024 and see the caliber of content you can expect at BIO 2025.

 
Loading
Search Filters
  • Date
  • Session Type
  • Focus Area
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
6:30 AM – 9:00 AM
(ET)
  1. KBI Biopharma 5K at BIO 2024
    Session
9:00 AM – 12:00 PM
(ET)
  1. Partnering with the U.S. Government to Achieve Our National Security Mission
    Breakout Session
    • Infectious Disease and Vaccines
    28ABCDE
10:00 AM – 11:00 AM
(ET)
  1. APAC: A Top Rate Destination for Complex and Challenging Clinical Trials
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    Sponsored by:
    novotech
11:00 AM – 11:45 AM
(ET)
  1. Funding from a Japanese Investment Perspective
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
11:30 AM – 1:00 PM
(ET)
  1. Premier & General Attendee Lunch
    Session Sails Pavilion
12:00 PM – 1:00 PM
(ET)
  1. How to Build a Successful and Competitive Biopharma Ecosystem in Southeast Asia
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
12:15 PM – 6:00 PM
(ET)
  1. Company Presentations Monday
    Company Presentation Session Company Presentation Theaters
    Sponsored by:
    johnson and johnson
12:30 PM – 1:30 PM
(ET)
  1. Sustainable Talent Development for Biomanufacturing of the Future
    BioProcess Theater BioProcess Theater
1:00 PM – 1:45 PM
(ET)
  1. APAC Summit Networking Lunch
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
1:45 PM – 2:45 PM
(ET)
  1. A Discussion on Increasing Healthspan
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
  2. A Licensing Deal for All Seasons
    Breakout Session
    • Business Development and Investment
    29AB
  3. All Money is NOT Created Equal: The Differences between Angel, Venture and Strategic Capital in the Biotech Funding Ecosystem
    Breakout Session
    • Business Development and Investment
    32AB
  4. Alternative Funding Programs: Protecting Patients in an Ever-Changing Healthcare Landscape
    Breakout Session
    • Patient Advocacy
    26A
  5. Building Capacities in the Industry for Secondary Uses of Health Data: The EHDS Framework
    Breakout Session
    • AI and Digital Health
    24BC
  6. Empowering Real World Patient-Centric Digital Health in Asia with Digital Apps
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
  7. Europe's Policy Environment and the Impact on the Biotech Sector
    Breakout Session
    • Emerging Opportunities in Global Markets
    26B
  8. Super Session
    Fireside Chat with Nauman Shah, Global Head of Business Development, Johnson & Johnson Innovative Medicine
    Super Session
    • Business Development and Investment
    28ABCDE
    Sponsored by:
    johnson and johnson
  9. Lessons from the Oregon Trail: Pioneering Gene Therapy in the Real World
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
  10. The Cross-Border Applicability of RWD in Decision-Making
    Breakout Session
    • Regulatory Innovation
    31C
  11. The Time is Now: Global Perspectives on Preparing for Public Health Emergencies
    Breakout Session
    • Infectious Disease and Vaccines
    29C
    Sponsored by:
    Emergent logo
2:00 PM – 2:45 PM
(ET)
  1. Digital Transformation for Start-up and Mid-sized Life Science manufacturing sites
    BioProcess Theater BioProcess Theater
3:00 PM – 4:00 PM
(ET)
  1. A New Era for Access and Affordability: Considerations for Patients and Manufacturers in a Post-IRA World
    Breakout Session
    • Patient Advocacy
    26A
  2. A Perspective from the Trenches: Challenges of Budgeting for Gene Therapies, Innovative Payment Systems That Work for Medicaid Departments and Patients, and What the States Need from CMS
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
  3. AI and Regulatory Innovation in Healthcare: Shaping the Future
    Breakout Session
    • Regulatory Innovation
    31C
  4. An Insider Look at Top Deals from 2023
    Breakout Session
    • Business Development and Investment
    29AB
  5. Biotech Beyond Borders: Emerging Stronger from a Complex Macroenvironment
    Breakout Session
    • Business Development and Investment
    32AB
  6. Capabilities for Advanced Biomanufacturing: Enhancing opportunities and meeting challenges for global access
    BioProcess Theater BioProcess Theater
  7. Emerging Technologies Fostering Biotech Innovation Globally
    Breakout Session
    • Emerging Opportunities in Global Markets
    26B
  8. Fireside Chat
    Fireside Chat with Nina Kjellson, General Partner, Canaan Partners
    Fireside Chat
    • Business Development and Investment
    30DE
  9. Fireside Chat
    Fireside Chat with Stephen Quake, Head of Science, Chan Zuckerberg Initiative
    Fireside Chat
    • Next Generation Biotherapeutics
    25ABC
  10. Forging New Pathways to Reimbursement for Digital Therapeutics: Considerations for Payer Coverage
    Breakout Session
    • AI and Digital Health
    24BC
  11. Global Policy Perspectives on the Next Generation of Rare Disease Medicines
    Breakout Session
    • Orphan and Rare Disease
    28ABCDE
    Sponsored by:

    merck logo

  12. Let’s Go STEDI: Moving Beyond QALY’s to Understand the True Value of Antimicrobials and Vaccines
    Breakout Session
    • Infectious Disease and Vaccines
    29C
  13. Longevity Therapeutics Enter Biopharma Mainstream
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
  14. Patients Wait Less: Streamlining Regulatory Pathways for Cell/Gene Therapies in Asia-Pacific Region
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
4:00 PM – 4:15 PM
(ET)
  1. Investissement Québec International
    Global Innovation Hub 30 December 1899 05:00:00
4:15 PM – 5:15 PM
(ET)
  1. Agile Biologics Development and Manufacturing Strategies to Meet Market Demand
    Breakout Session
    • Business Development and Investment
    30DE
    Sponsored by:
    thermofisher scientific
  2. Altering the Regulatory Ecosystem for Pediatric Clinical Programs: Intended and Unintended Consequences
    Breakout Session
    • Regulatory Innovation
    31C
  3. Avoid the Cycle of “Panic and Neglect": How Ongoing Commitment to Innovative Partnerships Futureproofs Against the Next Pandemic
    Breakout Session
    • Infectious Disease and Vaccines
    29C
  4. Creative Structures for Keeping Innovation Alive After the Deal
    Breakout Session
    • Business Development and Investment
    29AB
  5. Fireside Chat
    Fireside Chat with Matt Gline, CEO, Roivant Sciences
    Fireside Chat
    • Business Development and Investment
    25ABC
  6. From Patients to Partners: Patient Advocacy and Biotech Collaborate to Accelerate Innovation
    Breakout Session
    • Patient Advocacy
    26A
  7. Gun Violence Prevention: A Case Study in Passing Meaningful Policies in a Hyper Partisan Era
    Special Program
    • Regulatory Innovation
    28ABCDE
  8. Innovation Passport: Emerging Opportunities for Company Growth in Global Markets
    Breakout Session
    • Business Development and Investment
    32AB
  9. Investors' Perspectives: Digital Health Trends and Investment Thesis in 2024 and Beyond
    Breakout Session
    • AI and Digital Health
    24BC
  10. Quality Standards for Final Preparation of CGT Product at Point of Care (POC)
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
  11. Unlocking Biotech Growth: Hong Kong as the Gateway to Global Markets
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    Sponsored by:
    hkstp
  12. Unlocking Success to Biotech Global Expansion: A Stepwise Game Plan for International Launch
    Breakout Session
    • Emerging Opportunities in Global Markets
    26B
  13. Use of AI in mRNA: The New Revolution?
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
4:30 PM – 5:00 PM
(ET)
  1. Japan - Global Innovation Hub
    Global Innovation Hub 30 December 1899 05:00:00
9:00 AM – 10:30 AM
(ET)
  1. Main Stage Opening Program
    Main Stage Program Ballroom 20
  2. The Convergence of Entrepreneurship and Innovation featuring Viola Davis
    Main Stage Program Ballroom 20
10:30 AM – 5:00 PM
(ET)
  1. Company Presentations Tuesday
    Company Presentation Session Company Presentation Theaters
    Sponsored by:
    johnson and johnson
  2. Overcoming Development, Scale Up and Commercial Production Challenges for Novel Modalities
    BioProcess Theater BioProcess Theater
11:00 AM – 12:00 PM
(ET)
  1. AI's Trial by Fire: Experimental Validation in Drug Discovery
    Breakout Session
    • AI and Digital Health
    24BC
  2. Brick-by-Brick: Building a Biotech from Foundation Up with Venture Investor Company Formation
    Breakout Session
    • Business Development and Investment
    26B
  3. Build Your Product Pipeline with Non-Dilutive Federal Resources
    Breakout Session
    • Business Development and Investment
    29AB
  4. Building a Bioscience Economy Through Supportive State Legislation: A Discussion with State Legislators from California, Massachusetts, and the Midwest
    Special Program
    • Regulatory Innovation
    29C
  5. Super Session
    Decoding Biopharma's Public Image: Navigating 2024 Election Dynamics
    Super Session
    • Next Generation Biotherapeutics
    28ABCDE
    Sponsored by:
    Genentech logo
  6. FDA Townhall
    Special Program
    • Regulatory Innovation
    25ABC
  7. In and Out of This World: Partnering with Federal Labs
    Breakout Session
    • Business Development and Investment
    32AB
  8. Italian Trade Agency
    Global Innovation Hub 30 December 1899 05:00:00
  9. Navigating the Future of Cell and Gene Therapy: Strategies for Innovation, Collaboration, and Market Success
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    30ABC
    Sponsored by:
    cencora
  10. New Pain Therapeutics: Strategies for Innovation, Investment, and Collaboration
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
  11. Spurring Biotech Innovation And Access Across the Globe: A High- Level Discussion
    Breakout Session
    • Emerging Opportunities in Global Markets
    30DE
  12. Start-Up Stadium Tuesday Morning
    Start-Up Stadium 5B
  13. Strengthening of the Clinical Trials Environment in Europe Under the Accelerating Clinical Trials (ACT EU) Initiative
    Breakout Session
    • Clinical Trials Innovations
    31C
  14. Targeting the Brain: How Biotech is Uncovering the Biology of Brain Disease for Precision Neurotherapeutics
    Breakout Session
    • Brain Health
    26A
  15. What is Needed for Gene Therapy in the Future and How Close Are We?
    Session
11:15 AM – 11:30 AM
(ET)
  1. ICEX SPAIN TRADE & INVESTMENT
    Global Innovation Hub 30 December 1899 05:00:00
11:30 AM – 1:00 PM
(ET)
  1. Polish Investment and Trade Agency
    Global Innovation Hub 30 December 1899 05:00:00
  2. Premier & General Attendee Lunch
    Session Sails Pavilion
11:45 AM – 12:00 PM
(ET)
  1. Swiss Biotech Association
    Global Innovation Hub 30 December 1899 05:00:00
12:00 PM – 12:15 PM
(ET)
  1. Hong Kong Science & Technology Parks Corporation
    Global Innovation Hub 30 December 1899 05:00:00
12:15 PM – 1:30 PM
(ET)
  1. UK Government Department for Business and Trade
    Global Innovation Hub 30 December 1899 05:00:00
  2. Super Session
    Where to Launch? Expanding Beyond Home and Activating Your Product’s Global Potential
    Super Session
    • Emerging Opportunities in Global Markets
    28ABCDE
    Sponsored by:
    Cencora
12:30 PM – 12:45 PM
(ET)
  1. Taiwan BIO
    Global Innovation Hub 30 December 1899 05:00:00
12:45 PM – 1:00 PM
(ET)
  1. Belgian Pavilion
    Global Innovation Hub 30 December 1899 05:00:00
1:30 PM – 2:45 PM
(ET)
  1. Student Program: An Introduction to the Biotechnology Industry
    Special Program 29AB
1:45 PM – 2:45 PM
(ET)
  1. Accelerating the Globalization of Cell and Gene Therapies
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
  2. AI/ML is Transforming R&D and Business
    Breakout Session
    • AI and Digital Health
    24BC
  3. Creative Claiming for Platforms & Products: Designing an IP Strategy to Go Global
    Breakout Session
    • Intellectual Property and Legal Landscape
    26B
  4. Fireside Chat
    Fireside Chat with Robert A. Bradway, Chairman and Chief Executive Officer, Amgen
    Fireside Chat
    • Business Development and Investment
    25ABC
  5. Growth Opportunities from Women’s Health Investments
    Breakout Session
    • Business Development and Investment
    30DE
  6. How Should Biotechs Plan and Partner with CROs and Other Providers to Deliver Clinical Research and Maximize the Value of their Asset?
    Breakout Session
    • Business Development and Investment
    23BC
    Sponsored by:
    fortrea logo
  7. Joining Forces to Accelerate Innovation in Oncology
    Breakout Session
    • Oncology
    30ABC
    Sponsored by:
    Genentech logo
  8. NIH Support for Minority Health and Health Disparities Focused on Early-Stage Life Science Companies
    Breakout Session 31C
  9. Promising Advances in Neuroscience: New Molecular Targets and Biomarkers
    Breakout Session
    • Brain Health
    26A
  10. Strategies for Antimicrobial Access in LMICs
    Breakout Session
    • Infectious Disease and Vaccines
    29C
  11. The State of Emerging Biotechs: Investment, Deal, and Pipeline Trends
    Special Program
    • Business Development and Investment
    32AB
2:00 PM – 4:00 PM
(ET)
  1. Health~Holland
    Global Innovation Hub 30 December 1899 05:00:00
  2. Start-Up Stadium Tuesday Afternoon
    Start-Up Stadium 5B
2:15 PM – 2:30 PM
(ET)
  1. European Innovation Council
    Global Innovation Hub 30 December 1899 05:00:00
2:20 PM – 2:30 PM
(ET)
  1. Panel Discussion on Improving Expression and Manufacturing of Novel Biologics
    Session
2:30 PM – 2:45 PM
(ET)
  1. Department of Health Abu Dhabi
    Global Innovation Hub 30 December 1899 05:00:00
2:45 PM – 3:00 PM
(ET)
  1. Dubai Science Park
    Global Innovation Hub 30 December 1899 05:00:00
3:00 PM – 4:00 PM
(ET)
  1. Breaking the Cycle: Innovations in Addressing Substance Use Disorder
    Breakout Session
    • Brain Health
    26A
  2. Building a More Sustainable Biopharma Innovation Ecosystem
    Breakout Session
    • Environmental Sustainability
    29C
  3. Fireside Chat
    Fireside Chat with Joshua Boger, PhD, Founder and Former CEO of Vertex Pharmaceuticals; Executive Chairman, Alkeus Pharmaceuticals; Chair of Board, CervoMed
    Fireside Chat
    • Business Development and Investment
    25ABC
  4. From Incubation to Acquisition: The Growth Journey of an Early-Stage Company
    Breakout Session
    • Business Development and Investment
    30ABC
    Sponsored by:
    johnson and johnson
  5. Getting Personal: How the Evolving U.S. Privacy Legal Landscape Impacts Biomedical Research
    Breakout Session
    • AI and Digital Health
    24BC
  6. Microgravity: A Strategic Advantage in R&D
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
  7. Optimizing the Investability of Your Lead Program: Data-Driven Approaches for Pipeline Prioritization
    Breakout Session
    • Business Development and Investment
    32AB
  8. Preparing for Platforms: Sponsor and Regulator Perspectives on the Platform Technology Designation (PTD)
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
  9. Super Session
    Superconvergence: How the AI, Genetics, and Biotechnology Revolutions Will Transform our Lives, Work, and World, new book from Jamie Metzl
    Super Session
    • Next Generation Biotherapeutics
    28ABCDE
  10. The Bad and the Ugly: Unpacking Repercussions of the Medicaid Drug Rebate Program Rule
    Breakout Session
    • Value‚ Patient Access and Reimbursement
    29AB
  11. Workforce, Diversity, Equity, and Inclusion at BIO: Presenting New Survey Data and Exploring Partnerships
    Breakout Session 31C
3:15 PM – 3:30 PM
(ET)
  1. Japan Bioindustry Association
    Global Innovation Hub 30 December 1899 05:00:00
3:30 PM – 3:40 PM
(ET)
  1. Bioprocess Insider Interviews: Syngene
    Session
4:00 PM – 5:00 PM
(ET)
  1. Jamie Metzl Book Signing
    Special Program Sails Pavilion
4:15 PM – 5:15 PM
(ET)
  1. Adaptive Reuse: Biomanufacturing Enters A New Age
    Breakout Session
    • Environmental Sustainability
    29C
  2. AI-Generated Invention and the Future of Bio R&D
    Breakout Session
    • Intellectual Property and Legal Landscape
    26B
  3. Becoming an Early Innovation Partner of Choice
    Breakout Session
    • Business Development and Investment
    29AB
  4. Best Practices for Managing Your Biotech’s Ca$hflow
    Breakout Session
    • Business Development and Investment
    32AB
  5. Challenging Biotech’s One-Track Mind When it Comes to Neuropsychiatric Drug Innovation
    Breakout Session
    • Brain Health
    26A
  6. Exploring the Future of Gene Delivery: A Conversation on the Direction for Next-Generation Vectors
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
  7. Exploring the Uncharted: Rare Diseases, Unintended Consequences of the Inflation Reduction Act, and Demonstrating the Value of These Therapies
    Breakout Session
    • Orphan and Rare Disease
    30DE
    Sponsored by:
    alexion logo
  8. Fireside Chat
    Fireside Chat with Dr. Vivian Ota Wang, PhD, Deputy Director, NIH Office of Research on Women's Health
    Fireside Chat 25ABC
  9. Super Session
    Fireside Chat with John McDonald, Corporate Vice President, Global Head of Business Development and M&A, Novo Nordisk
    Super Session
    • Business Development and Investment
    28ABCDE
    Sponsored by:
    novo nordisk
  10. Future of Biopharma Innovation: Unleashing the Potential of Emerging Therapeutic Modalities in Oncology and Beyond
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
  11. Highlighting the Power of Patient Organizations: Exploring Initiatives That Drive Equitable Impact for Patients and Communities
    Breakout Session 31C
  12. The Future of Immunology: Path to Precision Medicine
    Breakout Session
    • Diagnostics and Personalized Medicine
    24BC
    Sponsored by:

    merck logo

9:00 AM – 10:30 AM
(ET)
  1. Keynote: Admiral William H. McRaven, U.S. Navy Four-Star Admiral (Retired)
    Main Stage Program Ballroom 20
  2. Main Stage Opening Program
    Main Stage Program Ballroom 20
10:30 AM – 4:10 PM
(ET)
  1. Incorporating New Technologies in Development and Production, Regulatory Landscapes, and Agile Manufacturing
    BioProcess Theater BioProcess Theater
11:00 AM – 1:00 PM
(ET)
  1. Achieving Commercial Success Through the National Institutes of Health's Intramural Research Program
    Breakout Session
    • Business Development and Investment
    32AB
  2. Biotech Partnering in Stormy Seas: Key Insights on Charting a Course to Successful Deal-Making through a Choppy Market
    Breakout Session
    • Business Development and Investment
    29AB
  3. Breaking the Rare Disease Deadlock through Multi-Stakeholder Collaboration
    Breakout Session
    • Orphan and Rare Disease
    26A
  4. How to De-Risk Drug Development from the Earliest Stages
    Breakout Session
    • Business Development and Investment
    23BC
    Sponsored by:
    parexel biotech
  5. Open Innovation in Life Sciences, Decades of Experiences, Time to Regroup!
    Breakout Session
    • Translational Research
    31AB
  6. Perspectives from Women Powerbrokers
    Breakout Session 31C
  7. Post-Guidance Opportunities and Challenges with Prescription Drug Use-Related Software (PDURS)
    Breakout Session
    • AI and Digital Health
    24BC
  8. Rising to the Challenge of Science Regulation: Ensuring Public Policy Keeps Pace with Innovation Ecosystem
    Breakout Session
    • Widening the Bioeconomy
    29C
  9. Start-Up Stadium Wednesday Morning
    Start-Up Stadium 5B
  10. Using AI/ML for Identification and Optimization of Therapeutic Molecules
    Breakout Session
    • AI and Digital Health
    30ABC
    Sponsored by:
    johnson and johnson
11:30 AM – 1:00 PM
(ET)
  1. Premier & General Attendee Lunch
    Session Sails Pavilion
12:00 PM – 5:00 PM
(ET)
  1. Company Presentations Wednesday
    Company Presentation Session Company Presentation Theaters
    Sponsored by:
    johnson and johnson
12:15 PM – 1:30 PM
(ET)
  1. Super Session
    From Chasing My Cure to Every Cure: Dr. David Fajgenbaum on the Power of AI to Repurpose Medicines [LUNCH IN ROOM]
    Super Session
    • Patient Advocacy
    28ABCDE
1:30 PM – 2:45 PM
(ET)
  1. Student Program: Entry into Early Careers in Biotechnology
    Special Program 29AB
1:45 PM – 2:45 PM
(ET)
  1. Advancing Innovation: Best Practices for University-Industry Collaboration
    Breakout Session
    • Translational Research
    31AB
  2. Applied AI & Advanced Automation in Clinical Development
    Breakout Session
    • AI and Digital Health
    30ABC
    Sponsored by:
    propharma
  3. Biotech Innovations for Pet Health
    Breakout Session
    • Widening the Bioeconomy
    29C
  4. Building Winning Presentations and Using Emotional Intelligence as a Tool for Success
    Breakout Session
    • Business Development and Investment
    32AB
  5. Cell Therapy Primer
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    23BC
  6. Diversifying the Talent Pipeline: Industry-Recognized Curriculum for a Skilled Workforce
    Breakout Session 31C
  7. New Tools, New Times: Chemical and Structural AI for Drug Discovery
    Breakout Session
    • AI and Digital Health
    24BC
  8. Pioneering Paths: Navigating the Frontiers of First-in-Class
    Breakout Session
    • Next Generation Biotherapeutics
    30DE
    Sponsored by:
    bayer
  9. The Oncology Endgame: Assemble and Shine with AI and Precision Medicine, or Lose.
    Breakout Session
    • Oncology
    26B
2:00 PM – 4:00 PM
(ET)
  1. Start-Up Stadium Wednesday Afternoon
    Start-Up Stadium 5B
3:00 PM – 4:00 PM
(ET)
  1. AI's Impact on Oncology Cancer Drug Development
    Breakout Session
    • Oncology
    26B
  2. Blueprints for Biotech: Designing Deals that Deliver
    Breakout Session
    • Business Development and Investment
    32AB
  3. Developing Successful DEI Programs for Life Sciences Companies
    Breakout Session 31C
  4. Driving Biotech Success: What Every CEO Needs from Her C-Level Team
    Breakout Session
    • Business Development and Investment
    29AB
  5. Navigating the Intersection of National Security and Advances in Emerging Biotechnology
    Breakout Session
    • Widening the Bioeconomy
    29C
  6. Obesity Therapies: Present and Future Opportunities
    Breakout Session
    • Business Development and Investment
    30ABC
    Sponsored by:
    novo nordisk
  7. Organizing to Derisk Academic Assets
    Breakout Session
    • Translational Research
    31AB
  8. PDABs and the IRA: The Impact of Federal Legislation on State-Level Prescription Pricing Practices
    Breakout Session
    • Value‚ Patient Access and Reimbursement
    23BC
  9. PFDDs and Beyond: Different Roads to Patient-Inspired Drug Development
    Breakout Session
    • Patient Advocacy
    25ABC
    Sponsored by:
    travere
  10. The Promise of Personalized Treatment Becoming Reality: How INT Could Change Oncology
    Breakout Session
    • Oncology
    26A
    Sponsored by:

    merck logo

  11. Thriving in the Age of Digital Insecurity: New Reporting Obligations and Cyber Resilience for Life Sciences Companies
    Breakout Session
    • AI and Digital Health
    24BC
  12. Vaccinating Against Mistrust and Misinformation During an Infodemic
    Breakout Session
    • Infectious Disease and Vaccines
    30DE
4:15 PM – 5:15 PM
(ET)
  1. Adult Vaccination: New Vaccines, New Opportunities to Protect Public Health
    Breakout Session
    • Infectious Disease and Vaccines
    32AB
    Sponsored by:

    merck logo

  2. Biotech as Climate Tech: Sustainable Production in Pharma, Ag, and Industry
    Breakout Session
    • Widening the Bioeconomy
    29C
  3. Co-opting Biological Processes to Drug Cancer and Other Diseases
    Breakout Session
    • Oncology
    26B
  4. Enhancing Clinical Trial Diversity Through a Patient-Centric, Data Driven Approach
    Breakout Session 31C
  5. Evolution of the IRA: A New-Year, a Potential New Administration, Yet Tackling the Same Access and Affordability Challenges
    Breakout Session
    • Value‚ Patient Access and Reimbursement
    23BC
  6. Fireside Chat
    Fireside Chat with FDA Commissioner Dr. Robert Califf
    Fireside Chat
    • Regulatory Innovation
    25ABC
  7. IPOs Are Starting to Come Back: Are You Ready?
    Breakout Session
    • Business Development and Investment
    29AB
  8. Moving from the Lab Bench to the Biotech C-Suite: Insights on Running a Founder-Led Biotech
    Breakout Session
    • Translational Research
    31AB
  9. Overcoming Systemic Data Bias via AI and Digital Health Tools: Perspectives from Providers, Pharma and Innovators
    Breakout Session
    • AI and Digital Health
    24BC
  10. Policy and Practice Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Precision Oncology
    Breakout Session
    • Diagnostics and Personalized Medicine
    26A
9:00 AM – 10:00 AM
(ET)
  1. Achieving the WHO Cervical Cancer Elimination Targets: The Value of Innovation in Achieving Pivotal Public Health Goals
    Breakout Session
    • Infectious Disease and Vaccines
    23BC
    Sponsored by:

    merck logo

  2. Exploring Deal-Making Options for Your Portfolio of Assets
    Breakout Session
    • Business Development and Investment
    29AB
  3. Immune System Biomarkers: Can Our Antibodies Predict How We Will React to Disease and Immunotherapy?
    Breakout Session
    • Diagnostics and Personalized Medicine
    26A
  4. New Approaches in Radiopharmaceuticals
    Breakout Session
    • Oncology
    31AB
  5. Revolutionizing Clinical Trials: Patient Registries, Wearable Tech, and Video Capture
    Breakout Session
    • Clinical Trials Innovations
    26B
  6. Surviving Turbulence: Extending Runway and Creating Value in Healthcare and Biotech
    Breakout Session
    • Business Development and Investment
    32AB
  7. The US Supreme Court and the End of Scientific Deference?
    Breakout Session
    • Regulatory Innovation
    31C
  8. What’s Nex-T: Innovator Roundtable on T Cell Therapies in Oncology
    Breakout Session
    • Oncology
    24BC
10:15 AM – 11:15 AM
(ET)
  1. Advancing the Global Regulatory Decision-Making with Public Private Partnerships
    Breakout Session
    • Regulatory Innovation
    31C
  2. Approaching the Tipping Point: The Emergence of Allogeneic Cell Therapy for Oncology
    Breakout Session
    • Oncology
    31AB
  3. Changing the Game: Innovation to End HIV
    Breakout Session
    • Infectious Disease and Vaccines
    23BC
  4. Competing as a Diagnostic Company in the Current Funding Environment: New Funding Models
    Breakout Session
    • Diagnostics and Personalized Medicine
    26A
  5. Inside the VC Playbook: Overcoming Obstacles in Challenging Markets for Success
    Breakout Session
    • Business Development and Investment
    32AB
  6. Is Oncology Still a Hot Spot for Biopharma Deals?
    Breakout Session
    • Oncology
    24BC
  7. Partnering with ARPA-H: New Opportunities and Best Practices for Engaging a Transformative R&D Funder
    Breakout Session
    • Business Development and Investment
    29AB
  8. Regulators & DTRA Enabling DCTs
    Breakout Session
    • Clinical Trials Innovations
    26B
10:30 AM – 1:00 PM
(ET)
  1. Company Presentations Thursday
    Company Presentation Session Company Presentation Theaters
    Sponsored by:
    johnson and johnson
  2. Risked Based Approach Commissioning and Qualification for organizations
    BioProcess Theater BioProcess Theater
11:00 AM – 1:00 PM
(ET)
  1. Start-Up Stadium Thursday
    Start-Up Stadium 5B
  2. Talent Development for a Digital World
    BioProcess Theater BioProcess Theater
11:30 AM – 12:45 PM
(ET)
  1. Immerse Yourself in the XR Future of Healthcare: Virtual Reality Demos and More
    Special Program
    • AI and Digital Health
    32AB
12:00 PM – 12:15 PM
(ET)
  1. BreakBio Corp
    Session
    • Oncology
    Company Presentation Theater 1
10:00 PM – 11:00 PM
(ET)
  1. Test session
    Session

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS

Loading

Search